Gb Sciences Inc (OP:GBLX)

0.0001 UNCHANGED

Delayed Quote Updated: 10:54 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gb Sciences Inc

Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday ↗

November 27, 2024

Discover 10 science-backed cannabis benefits for Thanksgiving, from reducing stress to boosting appetite, mood, and sleep quality.

Via Benzinga

Topics Cannabis

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study ↗

November 01, 2022

Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and...

Via Benzinga

New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids ↗

October 10, 2022

Biopharmaceutical research and drug development company, Gb Sciences, Inc. (OTCQB: GBLX), co-published a study in the journal Frontiers in Pharmacology that demonstrates the efficacy of its proprietary...

Via Benzinga

Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease ↗

April 12, 2022

Gb Sciences, Inc. (OTCQB: GBLX) has selected the University of Lethbridge in Canada to complete a dose range study of Gb Sciences' patent-protected formulations in a rodent model of Parkinson's...

Via Benzinga

Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes ↗

March 29, 2022

Gb Sciences, Inc.

Via Benzinga

Not So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers Clarify ↗

February 01, 2022

Following the promising study on cannabinoids and COVID-19 published by Oregon State University, Gb Sciences, Inc.

Via Benzinga

The Week In Cannabis: Tilray Earnings And Reactions, Weed And Covid, Italy, Marijuana At The Airport And More ↗

January 14, 2022

Below is a recap of the main news related to the cannabis industry and markets for the week of January 10, 2022.

Via Benzinga

Gb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma Industry ↗

January 11, 2022

Gb Sciences, Inc. (OTCQB:GBLX) announced Tuesday that it ha...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.